Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018208241) FORMULATION AND OPTIMIZATION OF CONTROLLED RELEASE TABLETS OF MORPHINE SULPHATE
Latest bibliographic data on file with the International BureauSubmit observation

Pub. No.: WO/2018/208241 International Application No.: PCT/TR2017/050178
Publication Date: 15.11.2018 International Filing Date: 10.05.2017
IPC:
A61K 9/20 (2006.01) ,A61K 31/00 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
20
Pills, lozenges or tablets
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
Applicants:
İLKO ILAÇ SANAYI VE TICARET ANONIM ŞIRKETI [TR/TR]; Veysel Karani Mahallesi Çolakoğlu Sokak No:10 Kat: 7-8-9 Sancaktepe/Istanbul, TR
Inventors:
ÖNCEL, Hatice; TR
ÇAPAN, Yilmaz; TR
PINARBAŞLI, Onur; TR
ARSLAN, Aslihan; TR
SARRAÇOĞLU, Nagehan; TR
Agent:
BULUT, Pinar; TR
Priority Data:
Title (EN) FORMULATION AND OPTIMIZATION OF CONTROLLED RELEASE TABLETS OF MORPHINE SULPHATE
(FR) FORMULATION ET OPTIMISATION DE COMPRIMÉS À LIBÉRATION CONTRÔLÉE DE SULFATE DE MORPHINE
Abstract:
(EN) A stable solid controlled release formulation having a prolonged release of the active agent comprising morphine and/or one or several pharmaceutically acceptable salts thereof. The controlled release tablet is formulated with a controlled release matrix, wherein the matrix comprises a dual-action polymer mix consisting of a hydrophilic 0 polymer and a hydrophobic polymer.
(FR) L'invention concerne une formulation à libération contrôlée solide stable présentant une libération prolongée de l'agent actif comprenant de la morphine et/ou un ou plusieurs sels pharmaceutiquement acceptables de celle-ci. Le comprimé à libération contrôlée est formulé avec une matrice à libération contrôlée, la matrice comprenant un mélange de polymères à double action constitué d'un polymère hydrophile et d'un polymère hydrophobe.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)